These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3542767)

  • 21. [Treatment of migraine attacks in children with dihydroergotamine Spofa and lysenyl].
    Vajnorský J
    Cesk Pediatr; 1986 Nov; 41(11):644-7. PubMed ID: 3814243
    [No Abstract]   [Full Text] [Related]  

  • 22. Management of migraine.
    Drug Ther Bull; 1981 Aug; 19(18):69-71. PubMed ID: 7261908
    [No Abstract]   [Full Text] [Related]  

  • 23. A controlled study of dihydroergotamine in the treatment of acute migraine headache.
    Callaham M; Raskin N
    Headache; 1986 Apr; 26(4):168-71. PubMed ID: 3519528
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of migraine attacks: combination of dihydroergotamine tartrate and paracetamol in comparison with individual drugs and placebo].
    Hoernecke R; Doenicke A
    Med Klin (Munich); 1993 Nov; 88(11):642-8. PubMed ID: 8295604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drugs for migraine.
    Med Lett Drugs Ther; 1995 Mar; 37(943):17-20. PubMed ID: 7862023
    [No Abstract]   [Full Text] [Related]  

  • 26. Timed-release dihydroergotamine in the prophylaxis of mixed headache. A study versus amitriptyline.
    Bonuso S; Di Stasio E; Barone P; Steardo L
    Cephalalgia; 1983 Aug; 3 Suppl 1():175-8. PubMed ID: 6352047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [What is safe in the treatment of headache?].
    Huffmann G
    Internist (Berl); 1981 Dec; 22(12):721-5. PubMed ID: 6119300
    [No Abstract]   [Full Text] [Related]  

  • 28. [Beta-endorphin and dihydroergotamine in migraine. Preliminary study].
    Pradalier A; Kerdelhue B; Dry J
    Therapie; 1984; 39(3):331-2. PubMed ID: 6087492
    [No Abstract]   [Full Text] [Related]  

  • 29. A literature review comparing the economic, clinical, and humanistic attributes of dihydroergotamine and sumatriptan.
    Kozma CM; Mauch RP; Reeder CE; Lawrence BJ
    Clin Ther; 1994; 16(6):1037-51; discussion 1036. PubMed ID: 7697683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abortive versus prophylactic treatment of migraine--a reappraisal.
    Mathew NT
    Headache; 1990 Mar; 30(4):238-9. PubMed ID: 2335480
    [No Abstract]   [Full Text] [Related]  

  • 31. [Calcium carbasalate-metoclopramide combination versus dihydroergotamine in the treatment of migraine attacks].
    Pradalier A; Guérard des Lauriers A; Scheck F; Peraudeau P; Lacoste JP; Cajfinger F
    Pathol Biol (Paris); 1995 Nov; 43(9):806-13. PubMed ID: 8746103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The treatment of migraine].
    Titus F
    Rev Neurol; 1997 Feb; 25(138):295-300. PubMed ID: 9147762
    [No Abstract]   [Full Text] [Related]  

  • 33. DHE-45 for acute migraine.
    Hagen N; Portenoy RK; Foley KM
    Neurology; 1989 Oct; 39(10):1408-9. PubMed ID: 2677838
    [No Abstract]   [Full Text] [Related]  

  • 34. Successful treatment of status migrainosus after electroconvulsive therapy with dihydroergotamine.
    Stead M; Josephs KA
    Headache; 2005 Apr; 45(4):378-80. PubMed ID: 15836577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A clinical comparison of sumatriptan nasal spray and dihydroergotamine nasal spray in the acute treatment of migraine.
    Boureau F; Kappos L; Schoenen J; Esperanca P; Ashford E
    Int J Clin Pract; 2000 Jun; 54(5):281-6. PubMed ID: 10954953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ergotamine tartrate and dihydroergotamine mesylate: safety profiles.
    Lipton RB
    Headache; 1997; 37 Suppl 1():S33-41. PubMed ID: 9009472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dihydroergotamine in prevention of infusion thrombophlebitis. A randomized trial.
    Jørgensen T; Wille-Jørgensen P; Kjaergaard J; Thorup J
    Acta Chir Scand; 1984; 150(1):21-2. PubMed ID: 6367325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DHE in the pharmacotherapy of migraine: potential for a larger role.
    Saper JR; Silberstein S; Dodick D; Rapoport A
    Headache; 2006 Nov; 46 Suppl 4():S212-20. PubMed ID: 17078853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Appropriate use of ergotamine tartrate and dihydroergotamine in the treatment of migraine: current perspectives.
    Young WB
    Headache; 1997; 37 Suppl 1():S42-5. PubMed ID: 9009473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Use of heparin in combination with dihydroergotamine for the postoperative prevention of thrombosis in hip joint surgery].
    Liedloff H; Brauckhoff KF; Heerdegen R; Barthel W
    Z Gesamte Inn Med; 1984 Sep; 39(17):428-31. PubMed ID: 6390998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.